Molecular pathogenesis of B cell malignancy: the role of BCL-6

被引：0
|
作者：
Dalla-Favera, R
Migliazza, A
Chang, CC
Niu, H
Pasqualucci, L
Butler, M
Shen, Q
Cattoretti, G
机构：
[1] Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA
[2] Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA
来源：
MECHANISMS OF B CELL NEOPLASIA 1998 | 1999年 / 246卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：257 / 265
页数：9
相关论文
共 50 条
  • [41] Common mechanisms for the regulation of B cell differentiation and transformation by the transcriptional repressor protein BCL-6
    Saritha Kusam
    Alexander Dent
    Immunologic Research, 2007, 37 : 177 - 186
  • [42] Prognostic significance of BCL-6 expression in diffuse large B-cell lymphomas (DLBCL)
    Karikehalli, S
    Nazeer, T
    MODERN PATHOLOGY, 2002, 15 (01) : 246A - 246A
  • [43] B cell priming for extrafollicular antibody responses requires Bcl-6 expression by T cells
    Lee, Sau K.
    Rigby, Robert J.
    Zotos, Dimitra
    Tsai, Louis M.
    Kawamoto, Shimpei
    Marshall, Jennifer L.
    Ramiscal, Roybel R.
    Chan, Tyani D.
    Gatto, Dominique
    Brink, Robert
    Yu, Di
    Fagarasan, Sidonia
    Tarlinton, David M.
    Cunningham, Adam F.
    Vinuesa, Carola G.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2011, 208 (07): : 1377 - 1388
  • [44] "Triple hit" lymphomas: A retrospective cytology case series of an uncommon high grade B-cell malignancy with C-MYC, BCL-2 and BCL-6 rearrangements
    Eldessouki, Tarek
    Hanley, Kelly
    Hamadeh, Fatima
    Oshilaja, Olaronke O.
    Sturgis, Charles D.
    DIAGNOSTIC CYTOPATHOLOGY, 2018, 46 (09) : 807 - 811
  • [45] Alterations on the 5′ noncoding region of the BCL-6 gene are not correlated with BCL-6 protein expression in T cell non-Hodgkin lymphomas
    Kerl, K
    Vonlanthen, R
    Nagy, M
    Bolzonello, NJ
    Gindre, P
    Hurwitz, N
    Gudat, F
    Nador, RG
    Borisch, B
    LABORATORY INVESTIGATION, 2001, 81 (12) : 1693 - 1702
  • [46] Rearrangements of bcl-1, bcl-2, bcl-6, and c-myc in diffuse large B-cell lymphomas
    Kawasaki, C
    Ohshima, K
    Suzumiya, J
    Kanda, M
    Tsuchiya, T
    Tamura, K
    Kikuchi, M
    LEUKEMIA & LYMPHOMA, 2001, 42 (05) : 1099 - 1106
  • [47] The relationship between BCL-2 and BCL-6 protein expression in diffuse large B-cell lymphoma (DLCL).
    Skinnider, BF
    DUpuis, B
    Gascoyne, RD
    MODERN PATHOLOGY, 1998, 11 (01) : 140A - 140A
  • [48] Antilymphoma therapy with a Bcl-6 inhibitor
    Peter McLaughlin
    Current Hematologic Malignancy Reports, 2009, 4 (4) : 183 - 184
  • [49] THE ADVANTAGE OF REARRANGING BCL-6 - REPLY
    KLUIN, PM
    NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (21): : 1460 - 1460
  • [50] Analysis of BCL-6 mutations in classic Hodgkin disease of the B- and T-cell type
    Seitz, V
    Hummel, M
    Anagnostopoulos, I
    Stein, H
    BLOOD, 2001, 97 (08) : 2401 - 2405
12345